Kevin L. Carter

Tenecteplase vs Alteplase for Acute Ischemic Stroke

07/23/2012

Although thrombolytic treatment with alteplase, a recombinant tissue plasminogen activator, is the accepted therapy for ischemic stroke, alteplase has been proven to be far from ideal. Tenecteplase, a genetically engineered mutant tissue...

Although thrombolytic treatment...

07/23/2012

First Report Managed Care

News Connection

Antibacterial Drugs and MRSA in Children

01/25/2012

Kevin L. Carter ;

Although methicillin resistance is common in Staphylococcus aureus in hospitals, the presence of such resistance in the community is also increasingly reported. It is commonly referred to as community-associated methicillin-resistant...

Although methicillin resistance...

01/25/2012

First Report Managed Care

Units and Costs of Comparable Insulin Supplied to Patients

05/17/2013

Kevin L. Carter ;

San Diego—Many companies that supply insulin can offer products with similar pharmacokinetic or pharmacodynamic (PK/PD) properties. This is the case with the active ingredients of insulin products produced by Eli Lilly and Company (LLY) and...

San Diego—Many companies that...

05/17/2013

First Report Managed Care

Effects of Norovirus VLP Vaccine

01/25/2012

Kevin L. Carter ;

Although noroviruses are a leading cause of epidemic acute gastroenteritis and sporadic cases of acute gastroenteritis, a reliable vaccine for these types of viruses has not yet been developed, nor has any specific therapy been developed to...

Although noroviruses are a...

01/25/2012

First Report Managed Care